Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com | Quantum-Si is redefining proteomic analysis by making single molecule protein analysis fast, simple, and accessible to every lab, everywhere. Powered by our core technology, Next-Gen Protein Sequencing™, Quantum-Si’s single-molecule platform enables kinetic measurements, revealing not just which proteins are present, but how they behave and interact within biological systems. By removing the complexity of traditional workflows like gels, Western blots, or specialized core facilities, Quantum-Si brings powerful, quantitative proteomic capabilities directly to the benchtop. It’s a new approach to protein analysis, one that provides both identification and quantitative understanding in a single platform with unparalleled resolution. With Quantum-Si, researchers gain deeper clarity into the molecular mechanisms that shape life, and the human condition. This advancement supports a new era of functional proteomics, accelerating discoveries across research, therapeutic development, and beyond.
Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. Founded based on a transformative technology invented at the University of Washington, Parse is used by over 1,000 labs across the world. Our growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, GigaLab, and a software tool for data analysis. | Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
PacBio
PacBio is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. | PacBio is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. PacBio products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our SBB® short read sequencing technologies. PacBio products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural aberrations. | Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. With real-time, multiomic nanopore sequencing, you can discover previously hidden human genomic, epigenomic, and transcriptomic variation — from the population to the single-cell level.
Ossvis America
OSSVIS is an innovator in digital dentistry, specializing in integrated dental solutions. Through its Lilivis brand, the company offers a complete digital workflow including intraoral scanners, CAD CAM software, milling machines, and 3D printers, designed to support efficient, accurate, and same day dental restorations.
Omega Bio-Tek
Omega Bio-tek is an ISO 9001:2015 and ISO 13485:2016 certified, industry-leading manufacturer of DNA/RNA purification kits for clinical, biotechnology, and genomics research. With a diversified product portfolio for low-throughout to high-throughput purification, our kits purify high-quality nucleic acids from a variety of samples. Our products and services are used worldwide. | For over 25 years, Omega Bio-tek has been an industry-leading provider of DNA/RNA purification kits and equipment for clinical, biotechnology, and genomics research. Operating under ISO 9001:2015 and ISO 13485:2016 certification, Omega Bio-tek provides a diversified product portfolio for low- and high-throughput purification of high-quality nucleic acids from a wide variety of sample types. Omega Bio-tek’s products and automation support services are used in thousands of universities and research laboratories in over 100 countries worldwide. Visit https://www.omegabiotek.com for more information on our products and services. Follow us on Twitter: @omegabiotek Connect with us on LinkedIn: Omega Bio-tek Like us on Facebook: @omegabiotek Follow us on Instagram: @omegabiotek
Metabolon
Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions. Metabolon’s unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules. Our proprietary Precision Metabolomics™ platform, combined with the world’s most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. Founded in 2000 and based in Research Triangle Park, North Carolina, Metabolon has conducted more than 10,000 independent and collaborative studies, resulting in 2,000+ publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit www.metabolon.com.